Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Hepatitis
Sort By
Newest First
Sign in
1 / 1
1 / 1
Commercial Agreement
Dicerna™ Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection
Novo Nordisk
PR-M10-19-NI-050
Nov 01, 2019
Safety Warning
Patient Deaths Lead to FDA Safety Warning on Hepatitis C Medication
Nice Insight
PAO-M09-19-NI-011
Sep 11, 2019
FDA Breakthrough
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
Nice Insight
PR-M08-19-NI-071
Aug 26, 2019
Drug Development
AbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis
AbbVie
PR-M11-18-NI-053
Nov 15, 2018
Hepatitis
MYR Pharma Announces Presentation of Interim Results of MYR 203, a Phase 2 Study of Myrcludex in Combination with Pegylated Interferon in Chronic Hepatitis Delta
MYR Pharma
PR-M10-18-NI-107
Oct 31, 2018
Combination Therapy
Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment
Emilie Branch
Pharma's Almanac
PAO-M08-17-NI-035
Aug 25, 2017
FDA
Vosevi Hepatitis C Treatment Approved by the FDA
Nigel Walker
Nice Insight
PAO-M07-17-NI-028
Jul 25, 2017
